Keywords
private equity group investors, dental support organizations, dental practice sale, squamous odontogenic tumor, utraosseous neoplasm, radiographic radiolucency, Sulfamethoxazole-trimethoprim side effects, thromocyclopenia oral manifestations, New York State child abuse reporting law, New York State Limited Liability Company reporting requirements, non-steroidal antiinflammatory medication contraindications, NSAID induced myocardial infarction and stroke, non-narcotic pain management
Abstract
In the March 2024 issue, the reader will find the following feature articles:
- Sulfamethoxazole-trimethoprim-Induced Thrombocytopenia
- Dentists and Oral Surgeons, Beware
- Squamous Odontogenic Tumor
This issue includes regular columns with regional news impacting the New York membership including: editorial and perspectives columns, legal, association activities, component news, continuing education opportunities, and classifieds.
Recommended Citation
(2024)
"N Y State Dent J March 2024,"
The New York State Dental Journal: Vol. 90:
No.
2, Article 1.
Available at:
https://commons.ada.org/nysdj/vol90/iss2/1